Screened 2026-08-20 · the tape above runs as of 23:26 UTC · 4 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Uber holds its Markup at $78.55. Elevated stress, defensive posture warranted, held for 13 days.
As held on the ledger · 2026-08-20
Phase
Markup
Quantitative state
Elevated stress, defensive posture warranted, held for 13 days
Price at the screen
$78.55
Valuation
17.23 trailing · 17.91 forward price to earnings
Values screen
PASS· score 79.1
Beta
1.15
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
19.55%
Below 33%
Interest-bearing debt is just 19.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
14.66%
Below 33%
Cash held in interest-bearing accounts and securities is 14.7% of assets, under the one-third limit.
Pass
Receivables
17.69%
Below 49%
Money owed to the company is 17.7% of assets, under the 49% limit.
Pass
Revenue purity
1.43%
Below 5%
Only 1.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades at roughly a 11% discount to our $86.78 fair value, moderate competitive moat, 12.20% revenue growth.
Fair value range in USD, drawn from the 2026-08-20 screen. The gold marker is the market price at the same screen. A 10.5% margin of safety to the base estimate.
Third-party analyst targets: 47 covering, consensus Buy. The average target sits +29% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-20 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Ridesharing Giant Beneath a Fair Value Cloud
Imagine every time you swipe right for a ride or order a meal, Uber is the silent conductor in the background, orchestrating the movement of people and goods. Uber's technology apps power the delivery of rides, food, and even freight, making it a significant player in the new economy. Why it stands out is clear - with a 12% revenue growth and a healthy 17% profit margin, Uber's financials are robust, and its forward P/E of 17.9x suggests a reasonable valuation, backed by our fair value of $86.78.
However, the market has priced Uber at $78.55, tagging it as overvalued in our books. Despite a strong 37% ROE and a moderate moat indicating competitive advantage, the consensus rating of 'buy' with a median target of $101 seems overly optimistic. The risk here is that these high expectations might not materialize, especially given the cyclical nature of some of Uber's segments, which could lead to a value trap if we're looking at peak earnings.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
UBER trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-05Markup · changed$78.55+19.1%Entry 11
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104.
2026-08-05Markdown$65.94+0.0%Entry 10
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04Markdown$65.94+0.0%Entry 9
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03Markdown$65.94+0.0%Entry 8
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Markdown$65.94+0.0%Entry 7
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Markdown$65.94+0.0%Entry 6
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31Markdown$65.94+0.0%Entry 5
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-30Markdown · changed$65.94-6.7%Entry 4
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Distribution$70.71+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (50 analysts) rates it strong buy, with a mean price target of $104.
2026-07-03Distribution$70.71+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
